Please login to the form below

Not currently logged in
Email:
Password:

Kisqali

This page shows the latest Kisqali news and features for those working in and with pharma, biotech and healthcare.

Novartis sales top £13bn in Q3 as the company reviews its generic business Sandoz

Novartis sales top £13bn in Q3 as the company reviews its generic business Sandoz

ruxolitinib) up by 26%, spinal muscular atrophy gene therapy Zolgensma (onasemnogene abeparvovec-xioi) up by 28%, and cancer medicine Kisqali (ribociclib), which grew by 27% in sales revenue. ... Key innovation milestones in Q3 include Kisqali

Latest news

More from news
Approximately 9 fully matching, plus 28 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...